SC
BMY icon

Stralem & Co’s Bristol-Myers Squibb BMY Stock Holding History

Stralem & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,300
Closed -$1M – 37
2018
Q4 		$1M Hold
19,300
– – 0.48% 36
2018
Q3 		$1.2M Buy
19,300
+1,500
+8% +$89K 0.36% 34
2018
Q2 		$985K Sell
17,800
-23,900
-57% -$1.29M 0.29% 36
2018
Q1 		$2.64M Buy
41,700
+800
+2% +$51.5K 0.52% 34
2017
Q4 		$2.51M Sell
40,900
-10,000
-20% -$625K 0.43% 34
2017
Q3 		$3.24M Buy
50,900
+500
+1% +$29.2K 0.47% 36
2017
Q2 		$2.81M Buy
50,400
+5,300
+12% +$288K 0.33% 36
2017
Q1 		$2.45M Hold
45,100
– – 0.29% 36
2016
Q4 		$2.64M Sell
45,100
-1,500
-3% -$82K 0.31% 36
2016
Q3 		$2.51M Sell
46,600
-900
-2% -$57.8K 0.29% 36
2016
Q2 		$3.49M Sell
47,500
-800
-2% -$56.5K 0.4% 36
2016
Q1 		$3.08M Sell
48,300
-23,200
-32% -$1.46M 0.34% 36
2015
Q4 		$4.92M Sell
71,500
-4,400
-6% -$291K 0.5% 36
2015
Q3 		$4.49M Sell
75,900
-11,100
-13% -$704K 0.37% 37
2015
Q2 		$5.79M Buy
87,000
+58,200
+202% +$3.84M 0.4% 37
2015
Q1 		$1.86M Sell
28,800
-700
-2% -$43.8K 0.1% 39
2014
Q4 		$1.74M Sell
29,500
-200
-0.7% -$11.3K 0.08% 38
2014
Q3 		$1.52M Hold
29,700
– – 0.06% 39
2014
Q2 		$1.44M Hold
29,700
– – 0.05% 38
2014
Q1 		$1.54M Sell
29,700
-800
-3% -$42.6K 0.05% 41
2013
Q4 		$1.62M Hold
30,500
– – 0.05% 41
2013
Q3 		$1.41M Sell
30,500
-300
-1% -$13.2K 0.04% 41
2013
Q2 		$1.38M Buy
+30,800
New +$1.34M 0.04% 40

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stralem & Co's BMY Position: Q1 2019 in Review

Stralem & Co sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 19,300 shares — an estimated $1M sold.

Stralem & Co first reported a position in BMY in Q2 2013 and held it in 23 quarters. The position peaked at $5.79M in Q2 2015. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Stralem & Co reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Stralem & Co sold 19,300 Bristol-Myers Squibb shares in Q1 2019, an estimated $1M.
  • Stralem & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 23 quarters.
  • Stralem & Co's Bristol-Myers Squibb position peaked at $5.79M in Q2 2015.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Stralem & Co's 13F filing for Q1 2019, filed 17 Apr 2019.